The B-Cube Tests are geno-molecular analyses that use transcriptome based NGS data focused on disease-linked markers and genetic pathways. A comprehensive report (approximately 20-30 pages) is provided, with an optional Orthomolecular and Pharmacotranscriptomic Report available for clinicians, detailing possible intervention options. A clinician may use this report in conjunction with other “standard of care” tests.
The BCube Tests currently available are:
• BCube Onco
BCube Onco is a BCube test focusing on cancer, providing more detailed information than the HrC screening test. This test can be used by cancer survivors to monitor recurrence and/or remission, and also by active cancer patients to monitor treatment efficacy.
• BCube Diabetes
For diabetic and pre-diabetic patients, for assistance in the management of their condition.
• BCube Cardiac
This test evaluates the risk of and/or current status of a variety of neurodegenerative diseases, including Alzheimers, Parkinsons and Huntingtons Disease.
• BCube Neuro
This test evaluates the risk/status of neurodegenerative diseases, including Alzheimer's, Parkinson's, and Huntington's Disease.